Voyager Therapeutics (VYGR) Revenue (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.13% |
| Dec 31, 2025 | 14.73% |
| Sep 30, 2025 | 157.69% |
| Jun 30, 2025 | -20.00% |
| Mar 31, 2025 | 3.16% |
| Dec 31, 2024 | -74.42% |
| Sep 30, 2024 | -16.79% |
| Jun 30, 2024 | 51.79% |
| Mar 31, 2024 | -78.36% |
| Dec 31, 2023 | 1,858.87% |
| Sep 30, 2023 | -6.12% |
| Jun 30, 2023 | -96.74% |
| Mar 31, 2023 | 9,808.39% |
| Dec 31, 2022 | -103.77% |
| Sep 30, 2022 | 5,670.51% |
| Jun 30, 2022 | 8.21% |
| Mar 31, 2022 | -97.66% |
| Dec 31, 2021 | 1,794.26% |
| Sep 30, 2021 | 9.21% |
| Jun 30, 2021 | -79.13% |
| Mar 31, 2021 | -0.55% |
| Dec 31, 2020 | -94.45% |
| Sep 30, 2020 | 310.87% |
| Jun 30, 2020 | 58.75% |
| Mar 31, 2020 | -44.71% |
| Dec 31, 2019 | 59.91% |
| Sep 30, 2019 | -55.66% |
| Jun 30, 2019 | 786.80% |
| Mar 31, 2019 | 158.81% |
| Dec 31, 2018 | -4.11% |
| Sep 30, 2018 | -18.68% |
| Jun 30, 2018 | 173.35% |
| Mar 31, 2018 | -85.16% |
| Dec 31, 2017 | 452.79% |
| Sep 30, 2017 | -2.46% |
| Jun 30, 2017 | -19.60% |
| Mar 31, 2017 | -38.02% |
| Dec 31, 2016 | -28.60% |
| Sep 30, 2016 | -11.08% |
| Jun 30, 2016 | -22.98% |
| Mar 31, 2016 | -2.17% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 1.09% |
| Jun 30, 2015 | 89.60% |